Draganfly to Host Shareholder Update Call Including Live Demo of its COVID-19 Focused Infectious Disease Screening Technology...
28 Octubre 2020 - 7:15AM
Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly”
or the “Company”), an award-winning, industry-leading manufacturer
within the commercial Unmanned Aerial Vehicle (“UAV”), Remotely
Piloted Aircraft Systems (“RPAS”), and Unmanned Vehicle Systems
(“UVS”) sectors, announced today that it will host a virtual-only
shareholder update call on October 29th, 2020 at 2PM MST/4PM EST.
The shareholder update call will be facilitated
by Draganfly CEO, Cameron Chell who will provide
an update on the state of the industry, Draganfly’s current
projects, customers, recent sales and the future-state road
map.
Earlier this week we announced launch of the
Draganfly Vital Intelligence API integration for telehealth
applications. The API enables telehealth applications to access the
Vital Intelligence technology which will enable such applications
to measure heart rate, respiratory rate and SPO2.
Dr. Jack Chow, Former US
Ambassador and Assistant Director-General of the World Health
Organization on Infectious Disease and current Draganfly board of
advisor member will address the current Global Pandemic scenario
and the important role of Draganfly.
Dr. Javaan Chahl, Defense
science and technology chair at the University of South Australia
and Chief Scientist for Draganfly’s Vital Intelligence platform
will provide a live demo of the Draganfly Vital Sign Assessment
technology which provides a quick, non-invasive (contactless) and
anonymous measurement of an elevated body temperature and, with
voluntary consent, heart rate, respiratory rate and blood
oxygenation all from a camera that takes seconds to capture.
“I am excited to provide an overview Draganfly’s
accomplishments and milestones. Draganfly has made great strides
across multiple revenue streams and verticals in the past six
months,” said Cameron Chell, Draganfly CEO. “I am also honoured to
be joined by Dr. Jack Chow who will discuss the current global
health environment and how Draganfly is positioned with its social
distancing and health measuring platform. In addition, Dr. Javaan
Chahl our Chief Scientist will provide a live demo of our Vital
Intelligence platform.”
Registration for the call can be done here.
The Company will answer pre-submitted
questions at the conclusion of prepared remarks. Investors are
asked to submit their questions
to investor.relations@draganfly.com.
About Draganfly
Draganfly Inc. (OTCQB: DFLYF; CSE: DFLY; FSE:
3U8) is the creator of quality, cutting-edge UVS and software that
revolutionize the way people do business. Recognized as being at
the forefront of technology for over 22 years, Draganfly is an
award-winning, industry-leading manufacturer within the commercial
UAV, RPAS, and UVS space, serving the public safety, agriculture,
industrial inspections, security, and mapping and surveying
markets. Draganfly is a company driven by passion, ingenuity, and
the need to provide efficient solutions and first-class services to
its customers around the world with the goal of saving time, money,
and lives.
For more information on Draganfly, please visit us
at www.draganfly.com. For additional investor information,
visit
https://www.thecse.com/en/listings/technology/draganfly-inc, https://www.otcmarkets.com/stock/DFLYF/overview or https://www.boerse-frankfurt.de/aktie/draganfly-inc.
Media Contact Arian Hopkins email:
media@draganfly.com
Company Contact Phone: 1-306-955-9907 Email:
info@draganfly.com
Forward-Looking Statements
This release contains certain “forward looking
statements” and certain “forward-looking information” as defined
under applicable Canadian securities laws. Forward-looking
statements and information can generally be identified by the use
of forward-looking terminology such as “may”, “will”, “expect”,
“intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans”
or similar terminology. Forward-looking statements and information
are based on forecasts of future results, estimates of amounts not
yet determinable and assumptions that, while believed by management
to be reasonable, are inherently subject to significant business,
economic and competitive uncertainties and contingencies.
Forward-looking statements and information are subject to various
known and unknown risks and uncertainties, many of which are beyond
the ability of the Company to control or predict, that may cause
the Company’s actual results, performance or achievements to be
materially different from those expressed or implied thereby, and
are developed based on assumptions about such risks, uncertainties
and other factors set out here in, including but not limited to:
the potential impact of epidemics, pandemics or other public health
crises, including the current outbreak of the novel coronavirus
known as COVID-19 on the Company’s business, operations and
financial condition, the successful integration of technology, the
inherent risks involved in the general securities markets;
uncertainties relating to the availability and costs of financing
needed in the future; the inherent uncertainty of cost estimates
and the potential for unexpected costs and expenses, currency
fluctuations; regulatory restrictions, liability, competition, loss
of key employees and other related risks and uncertainties. The
Company undertakes no obligation to update forward-looking
information except as required by applicable law. Such
forward-looking information represents managements’ best judgment
based on information currently available. No forward-looking
statement can be guaranteed and actual future results may vary
materially. Accordingly, readers are advised not to place undue
reliance on forward-looking statements or information.
Draganfly (CSE:DFLY)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Draganfly (CSE:DFLY)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024